Verrica PharmaceuticalsVRCA
13F holders, Q2 2026 (June 30)43holders +4
8new positions
5sold out
1famous investor
$6.12avg. 13F price*
At the end of Q2 2026, 43 institutions reported holding Verrica Pharmaceuticals Inc. (VRCA) in their 13F filings, up 4 from Q1 2026. 8 opened new positions and 5 sold out. The largest holders were Caligan Partners LP ($5.7M), Cannell Capital LLC ($4.8M) and Affinity Asset Advisors, LLC ($4.3M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Verrica Pharmaceuticals Inc.
- CUSIP
- 92511W207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $414K |
| Exits | 5 | $1.7M |
All 13F filers, Q1 2026 → Q2 2026: 493,471 shares bought and 608,916 shares sold, net −115,445 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 43 holders
| Caligan Partners LP | 0.27% | No change | 923,910 | $5.7M |
| Cannell Capital LLC | 3.35% | Add +14.4% | 783,923 | $4.8M |
| Affinity Asset Advisors, LLC | 0.22% | No change | 707,338 | $4.3M |
| Velan Capital Investment Management LP | 1.77% | No change | 471,559 | $2.9M |
| Armistice Capital, LLC | 0.07% | Reduce -17.7% | 426,304 | $2.6M |
| Boothbay Fund Management, LLC | 0.03% | No change | 280,734 | $1.7M |
| Vanguard Capital Management LLC | 0.00% | Add +48.0% | 279,310 | $1.7M |
| Mariner, LLC | 0.00% | Add +744.3% | 207,230 | $1.3M |
| Geode Capital Management, LLC | 0.00% | Reduce -0.5% | 138,160 | $846K |
| BlackRock, Inc. | 0.00% | Add +92.8% | 74,344 | $455K |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +7.8% | 70,173 | $429K |
| Two Sigma Investments, LP | 0.00% | Reduce -19.4% | 40,825 | $250K |
| State Street Corp. | 0.00% | No change | 28,916 | $177K |
| Northern Trust Corp. | 0.00% | Reduce -14.5% | 26,996 | $165K |
| DAFNA Capital Management LLC | 0.03% | Reduce -84.5% | 23,750 | $145K |
| Jane Street Group, LLC | 0.00% | Reduce -51.9% | 23,654 | $145K |
| Verdad Advisers, LP | 0.14% | Add +90.7% | 23,069 | $141K |
| Renaissance Technologies | 0.00% | Reduce -32.7% | 21,769 | $133K |
| Legacy Trust | 0.02% | Reduce -3.8% | 16,584 | $101K |
| Fifth Third Bancorp | 0.00% | New | 14,000 | $86K |
| Dimensional Fund Advisors LP | 0.00% | New | 13,888 | $85K |
| XTX Topco Ltd | 0.00% | New | 13,723 | $84K |
| Two Sigma Securities, LLC | 0.01% | New | 13,045 | $80K |
| HRT Financial LP | 0.00% | New | 13,023 | $79K |
| Beck Mack & Oliver LLC | 0.00% | No change | 12,000 | $73K |
| UBS Group AG | 0.00% | Add +42.2% | 6,071 | $37K |
| Morgan Stanley | 0.00% | Reduce -85.7% | 3,201 | $20K |
| Capital Analysts, LLC | 0.00% | No change | 1,500 | $9K |
| Vanguard Global Advisers, LLC | 0.00% | No change | 862 | $5K |
| Royal Bank of Canada | 0.00% | Reduce -20.8% | 764 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -28.3% | 614 | $4K |
| Salomon & Ludwin, LLC | 0.00% | No change | 290 | $2K |
| Allied Private Wealth LLC | 0.00% | — | 202 | $1K |
| New England Capital Financial Advisors LLC | 0.00% | No change | 200 | $1K |
| International Assets Investment Management, LLC | 0.00% | No change | 175 | $1K |
| Fortitude Family Office, LLC | 0.00% | No change | 127 | $777 |
| BNP Paribas Financial Markets | 0.00% | No change | 110 | $673 |
| PNC Financial Services Group, Inc. | 0.00% | No change | 102 | $624 |
| Barclays PLC | 0.00% | New | 64 | $392 |
| JPMorgan Chase & Co. | 0.00% | No change | 47 | $306 |
| Ameritas Advisory Services, LLC | 0.00% | New | 30 | $184 |
| Jones Financial Companies LLLP | 0.00% | No change | 26 | $178 |
| Valley National Advisers Inc. | 0.00% | New | 25 | $153 |
"% of holder's portfolio" is VRCA's weight in each manager's 13F, not the share of Verrica Pharmaceuticals Inc. the manager owns.